Durvalumab with or without tremelimumab in patients with persistent or recurrent endometrial cancer or endometrial carcinosarcoma: A randomized open-label phase 2 study-Reference-Cited by-同舟云学术

Durvalumab with or without tremelimumab in patients with persistent or recurrent endometrial cancer or endometrial carcinosarcoma: A randomized open-label phase 2 study

Published:2023-02 Issue: Volume:169 Page:64-69
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Rubinstein Maria M.,Doria Eric Rios,Konner Jason,Lichtman Stuart,Zhou Qin,Iasonos Alexia,Sarasohn Debra,Troso-Sandoval Tiffany,Friedman Claire,O'Cearbhaill Roisin,Cadoo Karen,Kyi Chrisann,Cohen Seth,Soldan Krysten,Billinson Eric,Caird Imogen,Jang Dasom,Eid Khalil,Shah Pooja,Guillen Joyce,Aghajanian Carol,Zamarin Dmitriy,Makker Vicky

Funder

National Cancer Institute

National Institutes of Health

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,Oncology

Reference35 articles.

1. Racial and ethnic differences in hysterectomy-corrected uterine Corpus Cancer mortality by stage and histologic subtype;Clarke;JAMA Oncol.,2022

2. The changing landscape of gynecologic Cancer mortality in the United States;Giaquinto;Obstet. Gynecol.,2022

3. Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States;Islami;CA Cancer J. Clin.,2018

4. Carboplatin and paclitaxel for advanced endometrial Cancer: final overall survival and adverse event analysis of a phase III trial (NRG oncology/GOG0209);Miller;J. Clin. Oncol.,2020

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bacterial pneumonia during successful treatment of metastatic endometrial cancer with dostarlimab- case report and a literature review;2024-08-28

2. Immunotherapy in MMR-d/MSI-H recurrent/metastatic endometrial cancer;Expert Review of Anticancer Therapy;2024-06-14

3. Immune Checkpoint Inhibitors and Cardiotoxicity: A Comparative Meta‐Analysis of Observational Studies and Randomized Controlled Trials;Journal of the American Heart Association;2024-05-21

4. High-Grade Endometrial Cancer: Molecular Subtypes, Current Challenges, and Treatment Options;Reproductive Sciences;2024-04-24

5. Immunotherapy in Cervical and Endometrial Cancer: Current Landscape and Future Directions;Life;2024-03-06